Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional study

BACKGROUND: Glatiramer acetate (GA) and interferon-beta (IFN-β) are disease-modifying therapies (DMTs) for multiple sclerosis that are administered through subcutaneous (SC) or intramuscular (IM) injections. Skin reactions associated with DMTs are common and may influence patient’s health-related qu...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Balak, Deepak MW, Hengstman, Gerald JD, Hajdarbegovic, Enes, van den Brule, Rob JP, Hupperts, Raymond MM, Thio, Hok Bing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854544/
https://ncbi.nlm.nih.gov/pubmed/24131589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-13-146
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia